ICH S1C (R2) Dose selection for carcinogenicity studies of pharmaceuticals

  • Email
  • Help
Current effective version

Adopted guideline

Reference numberCPMP/ICH/383/95
Published30/04/2008
Effective from01/10/2008
KeywordsCarcinogenity studies, dose selection, maximum tolerated dose (MTD), AUC ratio, saturation of absorption, maximum feasible dose, limit dose
DescriptionThis document outlines criteria for selection of the high dose for carcinogenicity studies of therapeutics. It proposes approaches that could be useful for dose selection.


Related content


How helpful is this page?

Average rating:

 Based on 0 ratings

Add your rating:

See all ratings
0 ratings
0 ratings
0 ratings
0 ratings
0 ratings
    

Tell us more